HEADER HORMONE/GROWTH FACTOR 23-APR-03 1P4O TITLE STRUCTURE OF APO UNACTIVATED IGF-1R KINASE DOMAIN AT 1.5A RESOLUTION. COMPND MOL_ID: 1; COMPND 2 MOLECULE: INSULIN-LIKE GROWTH FACTOR I RECEPTOR PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: CD221 ANTIGEN, IGF1R; COMPND 6 EC: 2.7.1.112; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IGF1R; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS IGF-1R, KINASE DOMAIN, HORMONE-GROWTH FACTOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.MUNSHI,M.KORNIENKO,D.L.HALL,P.L.DARKE,L.WAXMAN,L.C.KUO REVDAT 5 27-OCT-21 1P4O 1 SEQADV REVDAT 4 13-JUL-11 1P4O 1 VERSN REVDAT 3 24-FEB-09 1P4O 1 VERSN REVDAT 2 05-APR-05 1P4O 1 JRNL REVDAT 1 29-APR-03 1P4O 0 JRNL AUTH S.MUNSHI,D.L.HALL,M.KORNIENKO,P.L.DARKE,L.C.KUO JRNL TITL STRUCTURE OF APO, UNACTIVATED INSULIN-LIKE GROWTH FACTOR-1 JRNL TITL 2 RECEPTOR KINASE AT 1.5 A RESOLUTION. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 59 1725 2003 JRNL REFN ISSN 0907-4449 JRNL PMID 14501110 JRNL DOI 10.1107/S0907444903015415 REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 80.3 REMARK 3 NUMBER OF REFLECTIONS : 89007 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : 9.8% OF THE TOTAL REFLECTIONS REMARK 3 USED REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.236 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 10812 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4958 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 635 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1P4O COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-APR-03. REMARK 100 THE DEPOSITION ID IS D_1000019002. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 98666 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.07900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.55 REMARK 200 COMPLETENESS FOR SHELL (%) : 53.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.36000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.89 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.41 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 8% PEG 8K, 0.1M LICL, 10% ETHYLENE REMARK 280 GLYCOL, 10% GLYCEROL AND 0.1M TRIS-HCL BUFFER, PH 8.5, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 42.78000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2880 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 29680 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 943 REMARK 465 ALA A 944 REMARK 465 SER A 945 REMARK 465 VAL A 946 REMARK 465 ASN A 947 REMARK 465 LYS A 1256 REMARK 465 LEU A 1257 REMARK 465 PRO A 1258 REMARK 465 GLU A 1259 REMARK 465 PRO A 1260 REMARK 465 GLU A 1261 REMARK 465 GLU A 1262 REMARK 465 LEU A 1263 REMARK 465 ASP A 1264 REMARK 465 MET B 943 REMARK 465 ALA B 944 REMARK 465 SER B 945 REMARK 465 VAL B 946 REMARK 465 GLU B 1261 REMARK 465 GLU B 1262 REMARK 465 LEU B 1263 REMARK 465 ASP B 1264 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 949 -49.73 -131.98 REMARK 500 ASP A 960 -156.68 -135.06 REMARK 500 ARG A1104 -18.95 81.10 REMARK 500 LYS A1141 -140.76 -100.42 REMARK 500 PRO B 948 31.32 -59.75 REMARK 500 GLU B 949 -125.50 -163.10 REMARK 500 ASP B 960 -156.66 -137.21 REMARK 500 ASN B1028 73.43 -153.51 REMARK 500 ARG B1104 -17.46 81.68 REMARK 500 ASP B1105 42.09 -140.93 REMARK 500 LYS B1141 -136.53 -105.14 REMARK 500 GLU B1259 96.50 171.41 REMARK 500 REMARK 500 REMARK: NULL DBREF 1P4O A 944 1264 UNP P08069 IGF1R_HUMAN 974 1294 DBREF 1P4O B 944 1264 UNP P08069 IGF1R_HUMAN 974 1294 SEQADV 1P4O MET A 943 UNP P08069 INITIATING METHIONINE SEQADV 1P4O ALA A 1067 UNP P08069 GLU 1097 ENGINEERED MUTATION SEQADV 1P4O ALA A 1069 UNP P08069 GLU 1099 ENGINEERED MUTATION SEQADV 1P4O MET B 943 UNP P08069 INITIATING METHIONINE SEQADV 1P4O ALA B 1067 UNP P08069 GLU 1097 ENGINEERED MUTATION SEQADV 1P4O ALA B 1069 UNP P08069 GLU 1099 ENGINEERED MUTATION SEQRES 1 A 322 MET ALA SER VAL ASN PRO GLU TYR PHE SER ALA ALA ASP SEQRES 2 A 322 VAL TYR VAL PRO ASP GLU TRP GLU VAL ALA ARG GLU LYS SEQRES 3 A 322 ILE THR MET SER ARG GLU LEU GLY GLN GLY SER PHE GLY SEQRES 4 A 322 MET VAL TYR GLU GLY VAL ALA LYS GLY VAL VAL LYS ASP SEQRES 5 A 322 GLU PRO GLU THR ARG VAL ALA ILE LYS THR VAL ASN GLU SEQRES 6 A 322 ALA ALA SER MET ARG GLU ARG ILE GLU PHE LEU ASN GLU SEQRES 7 A 322 ALA SER VAL MET LYS GLU PHE ASN CYS HIS HIS VAL VAL SEQRES 8 A 322 ARG LEU LEU GLY VAL VAL SER GLN GLY GLN PRO THR LEU SEQRES 9 A 322 VAL ILE MET GLU LEU MET THR ARG GLY ASP LEU LYS SER SEQRES 10 A 322 TYR LEU ARG SER LEU ARG PRO ALA MET ALA ASN ASN PRO SEQRES 11 A 322 VAL LEU ALA PRO PRO SER LEU SER LYS MET ILE GLN MET SEQRES 12 A 322 ALA GLY GLU ILE ALA ASP GLY MET ALA TYR LEU ASN ALA SEQRES 13 A 322 ASN LYS PHE VAL HIS ARG ASP LEU ALA ALA ARG ASN CYS SEQRES 14 A 322 MET VAL ALA GLU ASP PHE THR VAL LYS ILE GLY ASP PHE SEQRES 15 A 322 GLY MET THR ARG ASP ILE TYR GLU THR ASP TYR TYR ARG SEQRES 16 A 322 LYS GLY GLY LYS GLY LEU LEU PRO VAL ARG TRP MET SER SEQRES 17 A 322 PRO GLU SER LEU LYS ASP GLY VAL PHE THR THR TYR SER SEQRES 18 A 322 ASP VAL TRP SER PHE GLY VAL VAL LEU TRP GLU ILE ALA SEQRES 19 A 322 THR LEU ALA GLU GLN PRO TYR GLN GLY LEU SER ASN GLU SEQRES 20 A 322 GLN VAL LEU ARG PHE VAL MET GLU GLY GLY LEU LEU ASP SEQRES 21 A 322 LYS PRO ASP ASN CYS PRO ASP MET LEU PHE GLU LEU MET SEQRES 22 A 322 ARG MET CYS TRP GLN TYR ASN PRO LYS MET ARG PRO SER SEQRES 23 A 322 PHE LEU GLU ILE ILE SER SER ILE LYS GLU GLU MET GLU SEQRES 24 A 322 PRO GLY PHE ARG GLU VAL SER PHE TYR TYR SER GLU GLU SEQRES 25 A 322 ASN LYS LEU PRO GLU PRO GLU GLU LEU ASP SEQRES 1 B 322 MET ALA SER VAL ASN PRO GLU TYR PHE SER ALA ALA ASP SEQRES 2 B 322 VAL TYR VAL PRO ASP GLU TRP GLU VAL ALA ARG GLU LYS SEQRES 3 B 322 ILE THR MET SER ARG GLU LEU GLY GLN GLY SER PHE GLY SEQRES 4 B 322 MET VAL TYR GLU GLY VAL ALA LYS GLY VAL VAL LYS ASP SEQRES 5 B 322 GLU PRO GLU THR ARG VAL ALA ILE LYS THR VAL ASN GLU SEQRES 6 B 322 ALA ALA SER MET ARG GLU ARG ILE GLU PHE LEU ASN GLU SEQRES 7 B 322 ALA SER VAL MET LYS GLU PHE ASN CYS HIS HIS VAL VAL SEQRES 8 B 322 ARG LEU LEU GLY VAL VAL SER GLN GLY GLN PRO THR LEU SEQRES 9 B 322 VAL ILE MET GLU LEU MET THR ARG GLY ASP LEU LYS SER SEQRES 10 B 322 TYR LEU ARG SER LEU ARG PRO ALA MET ALA ASN ASN PRO SEQRES 11 B 322 VAL LEU ALA PRO PRO SER LEU SER LYS MET ILE GLN MET SEQRES 12 B 322 ALA GLY GLU ILE ALA ASP GLY MET ALA TYR LEU ASN ALA SEQRES 13 B 322 ASN LYS PHE VAL HIS ARG ASP LEU ALA ALA ARG ASN CYS SEQRES 14 B 322 MET VAL ALA GLU ASP PHE THR VAL LYS ILE GLY ASP PHE SEQRES 15 B 322 GLY MET THR ARG ASP ILE TYR GLU THR ASP TYR TYR ARG SEQRES 16 B 322 LYS GLY GLY LYS GLY LEU LEU PRO VAL ARG TRP MET SER SEQRES 17 B 322 PRO GLU SER LEU LYS ASP GLY VAL PHE THR THR TYR SER SEQRES 18 B 322 ASP VAL TRP SER PHE GLY VAL VAL LEU TRP GLU ILE ALA SEQRES 19 B 322 THR LEU ALA GLU GLN PRO TYR GLN GLY LEU SER ASN GLU SEQRES 20 B 322 GLN VAL LEU ARG PHE VAL MET GLU GLY GLY LEU LEU ASP SEQRES 21 B 322 LYS PRO ASP ASN CYS PRO ASP MET LEU PHE GLU LEU MET SEQRES 22 B 322 ARG MET CYS TRP GLN TYR ASN PRO LYS MET ARG PRO SER SEQRES 23 B 322 PHE LEU GLU ILE ILE SER SER ILE LYS GLU GLU MET GLU SEQRES 24 B 322 PRO GLY PHE ARG GLU VAL SER PHE TYR TYR SER GLU GLU SEQRES 25 B 322 ASN LYS LEU PRO GLU PRO GLU GLU LEU ASP FORMUL 3 HOH *635(H2 O) HELIX 1 1 ALA A 965 GLU A 967 5 3 HELIX 2 2 SER A 1010 MET A 1024 1 15 HELIX 3 3 LYS A 1025 PHE A 1027 5 3 HELIX 4 4 ASP A 1056 ASN A 1071 1 16 HELIX 5 5 SER A 1078 ASN A 1099 1 22 HELIX 6 6 ALA A 1107 ARG A 1109 5 3 HELIX 7 7 ARG A 1128 TYR A 1135 5 8 HELIX 8 8 GLY A 1139 LYS A 1141 5 3 HELIX 9 9 PRO A 1145 MET A 1149 5 5 HELIX 10 10 SER A 1150 GLY A 1157 1 8 HELIX 11 11 THR A 1160 LEU A 1178 1 19 HELIX 12 12 SER A 1187 GLU A 1197 1 11 HELIX 13 13 PRO A 1208 TRP A 1219 1 12 HELIX 14 14 ASN A 1222 ARG A 1226 5 5 HELIX 15 15 SER A 1228 LYS A 1237 1 10 HELIX 16 16 GLU A 1238 MET A 1240 5 3 HELIX 17 17 GLU A 1241 PRO A 1242 5 2 HELIX 18 18 GLY A 1243 SER A 1248 1 6 HELIX 19 19 ALA B 965 GLU B 967 5 3 HELIX 20 20 SER B 1010 MET B 1024 1 15 HELIX 21 21 LYS B 1025 PHE B 1027 5 3 HELIX 22 22 ASP B 1056 ASN B 1071 1 16 HELIX 23 23 SER B 1078 ASN B 1099 1 22 HELIX 24 24 ALA B 1107 ARG B 1109 5 3 HELIX 25 25 ARG B 1128 TYR B 1135 5 8 HELIX 26 26 GLY B 1139 LYS B 1141 5 3 HELIX 27 27 PRO B 1145 MET B 1149 5 5 HELIX 28 28 SER B 1150 GLY B 1157 1 8 HELIX 29 29 THR B 1160 LEU B 1178 1 19 HELIX 30 30 SER B 1187 GLU B 1197 1 11 HELIX 31 31 PRO B 1208 TRP B 1219 1 12 HELIX 32 32 ASN B 1222 ARG B 1226 5 5 HELIX 33 33 SER B 1228 LYS B 1237 1 10 HELIX 34 34 GLU B 1238 MET B 1240 5 3 HELIX 35 35 GLU B 1241 PRO B 1242 5 2 HELIX 36 36 GLY B 1243 SER B 1248 1 6 HELIX 37 37 SER B 1252 LYS B 1256 5 5 SHEET 1 A 5 ILE A 969 GLN A 977 0 SHEET 2 A 5 MET A 982 VAL A 992 -1 O GLU A 985 N ARG A 973 SHEET 3 A 5 GLU A 995 THR A1004 -1 O ILE A1002 N TYR A 984 SHEET 4 A 5 LEU A1046 GLU A1050 -1 O MET A1049 N ALA A1001 SHEET 5 A 5 LEU A1035 VAL A1039 -1 N GLY A1037 O ILE A1048 SHEET 1 B 2 CYS A1111 VAL A1113 0 SHEET 2 B 2 VAL A1119 ILE A1121 -1 O LYS A1120 N MET A1112 SHEET 1 C 2 TYR A1136 ARG A1137 0 SHEET 2 C 2 LEU A1143 LEU A1144 -1 O LEU A1144 N TYR A1136 SHEET 1 D 5 ILE B 969 GLN B 977 0 SHEET 2 D 5 MET B 982 VAL B 992 -1 O GLU B 985 N ARG B 973 SHEET 3 D 5 GLU B 995 THR B1004 -1 O ILE B1002 N TYR B 984 SHEET 4 D 5 LEU B1046 GLU B1050 -1 O MET B1049 N ALA B1001 SHEET 5 D 5 LEU B1035 VAL B1039 -1 N GLY B1037 O ILE B1048 SHEET 1 E 2 CYS B1111 VAL B1113 0 SHEET 2 E 2 VAL B1119 ILE B1121 -1 O LYS B1120 N MET B1112 SHEET 1 F 2 TYR B1136 ARG B1137 0 SHEET 2 F 2 LEU B1143 LEU B1144 -1 O LEU B1144 N TYR B1136 CISPEP 1 GLN A 1043 PRO A 1044 0 -0.06 CISPEP 2 GLN B 1043 PRO B 1044 0 -0.11 CRYST1 52.950 85.560 78.880 90.00 99.10 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018886 0.000000 0.003025 0.00000 SCALE2 0.000000 0.011688 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012839 0.00000